发明申请
US20040214812A1 4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
失效
4-取代或未取代的7-氢-1,4-硫杂氮杂-7- [双环或三环杂芳基]取代-3,6-二羧酸衍生物作为β-内酰胺酶抑制剂
- 专利标题: 4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
- 专利标题(中): 4-取代或未取代的7-氢-1,4-硫杂氮杂-7- [双环或三环杂芳基]取代-3,6-二羧酸衍生物作为β-内酰胺酶抑制剂
-
申请号: US10834301申请日: 2004-04-28
-
公开(公告)号: US20040214812A1公开(公告)日: 2004-10-28
- 发明人: Tarek Suhayl Mansour , Aranapakam Mudumbai Venkatesan
- 申请人: Wyeth Holdings Corporation
- 申请人地址: US NJ Madison
- 专利权人: Wyeth Holdings Corporation
- 当前专利权人: Wyeth Holdings Corporation
- 当前专利权人地址: US NJ Madison
- 主分类号: A61K031/554
- IPC分类号: A61K031/554 ; C07D417/02
摘要:
The present invention relates to novel, low molecular weight broad spectrum compounds in particular to a class of 4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-nullbicyclic or tricyclic heteroarylnull substituted-3,6-dicarboxylic acid or their derivatives which have null-lactamase inhibitory and antibacterial properties. The compounds are therefore useful in the treatment of antibacterial infections in humans or animals, either alone or in combination with other antibiotics.
公开/授权文献
信息查询